Johnson & Johnson boasts a vast portfolio and a rock-solid balance sheet. AbbVie's main growth pillars are posting impressive ...

With $21.7 billion in cash and cash equivalents as of the end of the first quarter, the healthcare giant has the resources to ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.

A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD ...

Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS president Els ...

Three name-brand diabetes drugs and a blood thinner are now available at a discount on the government platform and J&J's own ...

During the study, investigators completed all procedures robotically on OTTAVA without conversion to a non-robotic approach.

Add Yahoo as a preferred source to see more of our stories on Google. On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked ...

Advances Company’s industry-leading portfolio in mental health with addition of CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an ...

On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked her parents to stay home from school, and they gave her one ...